Angiogenesis and tumor histologic type in primary breast cancer patients: An analysis of 155 needle core biopsies

Romanian Journal of Morphology and Embryology

Volumn 49, Issue 2, 2008, Pages 181-188

  Vamesu S ^a  

^a OVIDIUS UNIVERSITY   (Romania)

Author keywords

Angiogenesis; Breast carcinoma; Histologic type; Needle breast core biopsy

Indexed keywords

ADULT; ARTICLE; BREAST TUMOR; FEMALE; HUMAN; METHODOLOGY; MIDDLE AGED; NEEDLE BIOPSY; NEOVASCULARIZATION (PATHOLOGY); PAGET NIPPLE DISEASE; PATHOLOGY; RETROSPECTIVE STUDY; VASCULARIZATION;

ADULT; BIOPSY, NEEDLE; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; FEMALE; HUMANS; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; RETROSPECTIVE STUDIES;

EID: 52749093922     PISSN: 12200522     EISSN: 20668279     Source Type: Journal    
DOI: None     Document Type: Article

References (58)

1. nd edition, LippincottWilliams & Wilkins, Philadelphia, 2000.
2. nd edition,Lippincott Williams & Wilkins, Philadelphia, 2001.
3. WEIDNER N., COTE R. J., SUSTER S., WEISS L., ModernSurgical Pathology, Elsevier Science, Amsterdam, 2003, 891-892.
4. WINCHESTER D. J., CHANG H. R., GRAVES T. A., MENCK H. R., BLAND K. I., WINCHESTER D. P., A comparativeanalysis of lobular and ductal carcinoma of the breast: presentation, treatment, and outcomes, J Am Coll Surg, 1998, 186(4):416-422.
5. NEWSTEAD G. M., BAUTE P. B., TOTH H. K., Invasive lobular and ductal carcinoma: mammographic findings and stage atdiagnosis, Radiology, 1992, 184(3):623-627; erratum in: Radiology, 1992, 185(2):616.
6. PEIRO G., BORNSTEIN B. A., CONNOLLY J. L., GELMAN R., HETELEKIDIS S., NIXON A. J., RECHT A., SILVER B., HARRIS J. R., SCHNITT S. J., The influence of infiltrating lobular carcinoma on the outcome of patients treated with breast-conserving surgery and radiation therapy, Breast Cancer Res Treat, 2000, 59(1):49-54.
7. MOLLAND J. G., DONNELLAN M., JANU N. C., CARMALT H. L., KENNEDY C. W., GILLETT D. J., Infiltrating lobularcarcinoma a comparison of diagnosis, management and outcome with infiltrating duct carcinoma, Breast, 2004, 13(5):389-396.
8. JAIN S., FISHER C., SMITH P., MILLIS R. R., RUBENS R. D., Patterns of metastatic breast cancer in relation tohistological type, Eur J Cancer, 1993, 29A(15):2155-2157.
9. BORST M. J., INGOLD J. A., Metastatic patterns of invasivelobular versus invasive ductal carcinoma of the breast, Surgery, 1993, 114(4):637-641; discussion 641-642.
10. NEWMAN L. A., BUZDAR A. U., SINGLETARY S. E., KUERER H. M., BUCHHOLZ T., AMES F. C., ROSS M. I., HUNT K. K., A prospective trial of preoperative chemotherapy in resectable breast cancer: predictors of breast-conservation therapy feasibility, Ann Surg Oncol, 2002, 9(3):228-234.
11. DIXON A. R., ELLIS I. O., ELSTON C. W., BLAMEY R. W., A comparison of the clinical metastatic patterns of invasivelobular and ductal carcinomas of the breast, Br J Cancer, 1991, 63(4):634-635.
12. BUMPERS H. L., HASSETT J. M. JR., PENETRANTE R. B., HOOVER E. L., HOLYOKE E. D., Endocrine organ metastasesin subjects with lobular carcinoma of the breast, Arch Surg, 1993, 128(12):1344-1347.
13. Sastre-Garau X., JOUVE M., ASSELAIN B., Vincent-Salomon A., BEUZEBOC P., DORVAL T., DURAND J. C., FOURQUET A., POUILLART P., Infiltrating lobular carcinoma of the breast. Clinicopathologic analysis of 975 cases with reference to data on conservative therapy and metastatic patterns, Cancer, 1996, 77(1):113-120.
14. YEATMAN T. J., CANTOR A. B., SMITH T. J., SMITH S. K., REINTGEN D. S., MILLER M. S., KU N. N., BAEKEY P. A., COX C. E., Tumor biology of infiltrating lobular carcinoma. Implications for management, Ann Surg, 1995, 222(4):549-561.
15. TOIKKANEN S., PYLKKÄNEN L., JOENSUU H., Invasive lobular carcinoma of the breast has better short and long-termsurvival than invasive ductal carcinoma, Br J Cancer, 1997, 76(9):1234-1240.
16. FOLKMAN J., Role of angiogenesis in tumor growth and metastasis, Semin Oncol, 2002, 29(6 Suppl 16):15-18.
17. FOLKMAN J., Clinical application of research onangiogenesis, N Engl J Med, 1995, 333(26):1757-1763.
18. KATO T., KIMURA T., ISHII N., FUJII A., YAMAMOTO K., KAMEOKA S., NISHIKAWA T., KASAJIMA T., The methodology of quantitation of microvessel density and prognostic value of neovascularization associated with long-term survival in Japanese patients with breast cancer, Breast Cancer Res Treat, 1999, 53(1):19-31.
19. WEIDNER N., SEMPLE J. P., WELCH W. R., FOLKMAN J., Tumor angiogenesis and metastasis correlation ininvasive breast carcinoma, N Engl J Med, 1991, 324(1):1-8.
20. LEEK R. D., The prognostic role of angiogenesis in breast cancer, Anticancer Res, 2001, 21(6B):4325-4331.
21. SAARISTO A., KARPANEN T., ALITALO K., Mechanismsof angiogenesis and their use in the inhibition of tumor growth and metastasis, Oncogene, 2000, 19(53):6122-6129.
22. GASPARINI G., Clinical significance of determination of surrogate markers of angiogenesis in breast cancer, Crit Rev Oncol Hematol, 2001, 37(2):97-114.
23. GOULDING H., ABDUL RASHID N. F., ROBERTSON J. F., BELL J. A., ELSTON C. W., BLAMEY R. W., ELLIS I. O., Assessment of angiogenesis in breast carcinoma: an important factor in prognosis?, Hum Pathol, 1995, 26(11):1196-1200.
24. VAN HOEF M. E., KNOX W. F., DHESI S. S., HOWELL A., SCHOR A. M., Assessment of tumour vascularity as aprognostic factor in lymph node negative invasive breast cancer, Eur J Cancer, 1993, 29A(8):1141-1145.
25. GAJDOS C., TARTTER P. I., BLEIWEISS I. J., HERMANN G., DE CSEPEL J., ESTABROOK A., RADEMAKER A. W., Mammographic appearance of nonpalpable breast cancer reflects pathologic characteristics, Ann Surg, 2002, 235(2):246-251.
26. VERKOOIJEN H. M., CORE BIOPSY AFTER RADIOLOGICAL LOCALISATION (COBRA) STUDY GROUP, Diagnostic accuracyof stereotactic large-core needle biopsy for nonpalpable breast disease: results of a multicenter prospective study with 95% surgical confirmation, Int J Cancer, 2002, 99(6):853-859.
27. PARKER S. H., LOVIN J. D., JOBE W. E., BURKE B. J., HOPPER K. D., YAKES W. F., Nonpalpable breast lesions:stereotactic automated large-core biopsies, Radiology, 1991, 180(2):403-407.
28. ELVECROG E. L., LECHNER M. C., NELSON M. T., Nonpalpable breast lesions: correlation of stereotaxic large-core needle biopsy and surgical biopsy results, Radiology, 1993, 188(2):453-455.
29. DRONKERS D. J., Stereotaxic core biopsy of breast lesions, Radiology, 1992, 183(3):631-634.
30. rd edition, Reston,1998.
31. ELLIS I. O., SCHNITT S. J., Sastre-Garau X. et al., Invasive breast carcinoma. In: TAVASSOLI F. A., DEVILEE P. (eds), World Health Organization Classification of Tumours. Pathology and genetics of tumours of the breast and female genital organs, IARC Press, Lyon, 2003, 13-59.
32. KOWALSKI P. J., RUBIN M. A., KLEER C. G., E-cadherin expression in primary carcinomas of the breast andits distant metastases, Breast Cancer Res, 2003, 5(6):R217-R222.
33. VOS C. B., Cleton-Jansen A. M., BERX G., DE LEEUW W. J., TER HAAR N. T., VAN ROY F., CORNELISSE C. J., PETERSE J. L., VAN DE VIJVER M. J., E-cadherin inactivation in lobular carcinoma in situ of the breast: an early event in tumorigenesis, Br J Cancer, 1997, 76(9):1131-1133.
34. GUPTA D., CROITORU C. M., AYALA A. G., SAHIN A. A., MIDDLETON L. P., E-cadherin immunohistochemical analysis of histiocytoid carcinoma of the breast, Ann Diagn Pathol, 2002, 6(3):141-147.
35. Rieger-Christ K. M., PEZZA J. A., DUGAN J. M., BRAASCH J. W., HUGHES K. S., SUMMERHAYES I. C., Disparate E-cadherin mutations in LCIS and associated invasive breast carcinomas, Mol Pathol, 2001, 54(2):91-97.
36. GOLDSTEIN N. S., BASSI D., WATTS J. C., LAYFIELD L. J., YAZIJI H., GOWN A. M., E-cadherin reactivity of 95 noninvasive ductal and lobular lesions of the breast. Implications for the interpretation of problematic lesions, Am J Clin Pathol, 2001, 115(4):534-542.
37. LEHR H. A., FOLPE A., YAZIJI H., KOMMOSS F., GOWN A. M., Cytokeratin 8 immunostaining pattern and E-cadherinexpression distinguish lobular from ductal breast carcinoma, Am J Clin Pathol, 2000, 114(2):190-196.
38. ACS G., LAWTON T. J., REBBECK T. R., LIVOLSI V. A., ZHANG P. J., Differential expression of E-cadherin in lobularand ductal neoplasms of the breast and its biologic and diagnostic implications, Am J Clin Pathol, 2001, 115(1):85-98.
39. BRATTHAUER G. L., MOINFAR F., STAMATAKOS M. D., MEZZETTI T. P., SHEKITKA K. M., MAN Y. G., TAVASSOLI F. A., Combined E-cadherin and high molecular weight cytokeratin immunoprofile differentiated lobular, ductal, and hybrid mammary intraepithelial neoplasia, Hum Pathol, 2002, 33(6):620-627.
40. WELLINGS S. R., JENSEN H. M., MARCUM R. G., An atlas of subgross pathology of the human breast with specialreference to possible precancerous lesions, J Natl Cancer Inst, 1975, 55(2):231-273.
41. WELLINGS S. R., Development of human breast cancer, Adv Cancer Res, 1980, 31:287-314.
42. RUSSO J., GUSTERSON B. A., ROGERS A. E., RUSSO I. H., WELLINGS S. R., VAN ZWIETEN M. J., Comparative study ofhuman and rat mammary tumorigenesis, Lab Invest, 1990, 62(3):244-278.
43. RUSSO J., HU Y. F., SILVA I. D., RUSSO I. H., Cancer risk related to mammary gland structure and development, Microsc Res Tech, 2001, 52(2):204-223.
44. RUSSO J., RUSSO I. H., Toward a physiological approach to breast cancer prevention, Cancer Epidemiol Biomarkers Prev, 1994, 3(4):353-364.
45. LI C. I., ANDERSON B. O., PORTER P., HOLT S. K., DALING J. R., MOE R. E., Changing incidence rate ofinvasive lobular breast carcinoma among older women, Cancer, 2000, 88(11):2561-2569.
46. LI C. I., WEISS N. S., STANFORD J. L., DALING J. R., Hormone replacement therapy in relation to risk of lobular and ductalbreast carcinoma in middle-aged women, Cancer, 2000, 88(11):2570-2577.
47. LI C. I., ANDERSON B. O., DALING J. R., MOE R. E., Trends in incidence rates of invasive lobular and ductal breastcarcinoma, JAMA, 2003, 289(11):1421-1424.
48. DALING J. R., MALONE K. E., DOODY D. R., VOIGT L. F., BERNSTEIN L., COATES R. J., MARCHBANKS P. A., NORMAN S. A., WEISS L. K., URSIN G., BERLIN J. A., BURKMAN R. T., DEAPEN D., FOLGER S. G., MCDONALD J. A., SIMON M. S., STROM B. L., WINGO P. A., SPIRTAS R., Relation of regimens of combined hormone replacement therapy to lobular, ductal, and other histologic types of breast carcinoma, Cancer, 2002, 95(12):2455-2464.
49. VERKOOIJEN H. M., FIORETTA G., VLASTOS G., MORABIA A., SCHUBERT H., SAPPINO A. P., PELTE M. F., SCHÄFER P., KURTZ J., BOUCHARDY C., Important increase of invasive lobular breast cancer incidence in Geneva, Switzerland, Int J Cancer, 2003, 104(6):778-781.
50. GUPTA A., DESHPANDE C. G., BADVE S., Role of E-cadherins in development of lymphatic tumor emboli, Cancer, 2003,97(9):2341-2347.
51. ARPINO G., BARDOU V. J., CLARK G. M., ELLEDGE R. M., Infiltrating lobular carcinoma of the breast: tumorcharacteristics and clinical outcome, Breast Cancer Res, 2004, 6(3):149-156.
52. FERLICOT S., Vincent-Salomon A., MÉDIONI J., GENIN P., ROSTY C., Sigal-Zafrani B., FRÉNEAUX P., JOUVE M., THIERY J. P., Sastre-Garau X., Wide metastatic spreading in infiltrating lobular carcinoma of the breast, Eur J Cancer, 2004, 40(3):336-341.
53. PAUMIER A., SAGAN C., CAMPION L., FICHE M., ANDRIEUX N., DRAVET F., PIOUD R., CLASSE J. M., Accuracy ofconservative treatment for infiltrating lobular breast cancer: a retrospective study of 217 infiltrating lobular carcinomas and 2155 infiltrating ductal carcinomas, J Gynecol Obstet Biol Reprod (Paris), 2003, 32(6):529-534.
54. SILVERSTEIN M. J., LEWINSKY B. S., WAISMAN J. R., GIERSON E. D., COLBURN W. J., SENOFSKY G. M., GAMAGAMI P., Infiltrating lobular carcinoma. Is it different from infiltrating duct carcinoma?, Cancer, 1994, 73(6):1673-1677.
55. HANAHAN D., WEINBERG R. A., The hallmarks of cancer, Cell, 2000, 100(1):57-70.
56. WEIDNER N., FOLKMAN J., Tumoral vascularity as a prognostic factor in cancer, Important Adv Oncol, 1996,167-190.
57. Folkman J., Fundamental concepts of the angiogenic process, Curr Mol Med, 2003, 3(7):643-651.
58. FITZGIBBONS P. L., PAGE D. L., WEAVER D., THOR A. D., ALLRED D. C., CLARK G. M., RUBY S. G., O'Malley F., SIMPSON J. F., CONNOLLY J. L., HAYES D. F., EDGE S. B., LICHTER A., SCHNITT S. J., Prognostic factors in breast cancer. College of American Pathologists Consensus Statement 1999, Arch Pathol Lab Med, 2000, 124(7):966-978.